Logo do repositório

Are Costs Decisive in the Incorporation of Medicines for the Treatment of Ultra-Rare Diseases in Brazil? Trends in Healthcare Coverage for Ultra-Rare Diseases

dc.contributor.authorLopes, Luciane Cruz
dc.contributor.authorPereira Curado, Daniel da Silva
dc.contributor.authorMachado-Rugolo, Juliana
dc.contributor.authorPaula de Sordi, Monica Aparecida de
dc.contributor.authorKomoda, Denis Satoshi
dc.contributor.authorModelli de Andrade, Luis Gustavo
dc.contributor.authorTheresa Weber, Silke Anna [UNESP]
dc.contributor.authorTarride, Jean Eric
dc.contributor.authorThabane, Lehana
dc.contributor.authorSantos, Marisa
dc.contributor.authorAlmeida Cardoso, Marilia Mastrocolla de
dc.contributor.institutionUniv Sorocaba
dc.contributor.institutionMinist Hlth
dc.contributor.institutionHosp Clin Fac Med Botucatu HCFMB
dc.contributor.institutionUniversidade Estadual de Campinas (UNICAMP)
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionMcMaster Univ
dc.contributor.institutionNatl Inst Cardiol
dc.date.accessioned2025-04-29T18:48:26Z
dc.date.issued2024-11-01
dc.description.affiliationUniv Sorocaba, Pharmaceut Sci Grad Course, Sorocaba, SP, Brazil
dc.description.affiliationMinist Hlth, Brasilia, DF, Brazil
dc.description.affiliationHosp Clin Fac Med Botucatu HCFMB, Hlth Technol Assessment, Botucatu, SP, Brazil
dc.description.affiliationUniv Estadual Campinas, Campinas, SP, Brazil
dc.description.affiliationHosp Clin Fac Med Botucatu HCFMB, Lab Data Sci & Predict Anal Hlth, Botucatu, SP, Brazil
dc.description.affiliationSao Paulo State Univ Unesp, Botucatu Med Sch FMB, Botucatu, SP, Brazil
dc.description.affiliationMcMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada
dc.description.affiliationNatl Inst Cardiol, Rio De Janeiro, RJ, Brazil
dc.description.affiliationUnespSao Paulo State Univ Unesp, Botucatu Med Sch FMB, Botucatu, SP, Brazil
dc.format.extent673-674
dc.identifier.citationPharmacoepidemiology And Drug Safety. Hoboken: Wiley, v. 33, p. 673-674, 2024.
dc.identifier.issn1053-8569
dc.identifier.urihttps://hdl.handle.net/11449/300047
dc.identifier.wosWOS:001407925904090
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofPharmacoepidemiology And Drug Safety
dc.sourceWeb of Science
dc.titleAre Costs Decisive in the Incorporation of Medicines for the Treatment of Ultra-Rare Diseases in Brazil? Trends in Healthcare Coverage for Ultra-Rare Diseasesen
dc.typeResumopt
dcterms.licensehttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dcterms.rightsHolderWiley-Blackwell
dspace.entity.typePublication
relation.isOrgUnitOfPublicationa3cdb24b-db92-40d9-b3af-2eacecf9f2ba
relation.isOrgUnitOfPublication.latestForDiscoverya3cdb24b-db92-40d9-b3af-2eacecf9f2ba
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt

Arquivos